Diamonds and Dogs
2/11/13
Novo Nordisk A/S (NVO)Novo Nordisk is burning up today, down 13.97% at $165.42. The international healthcare and pharmaceutical company saw its shares crash after the FDA rejected two of the company's drugs. The FDA declined approval for Tresiba and Ryzodeg, both of which are insulin related. The FDA stated that the drugs were not approved because the FDA wanted to see more cardiovascular data. Novo Nordisk management said that they will not be able to complete the cardiovascular data this year. The company is still well above its 52-week low of $129.41.
JinkoSolar Holding Co. Ltd. (JKS)
JinkoSolar is shining today, up 8.36% at $8.68. The Chinese solar panel company saw its shares explode after news that it was issuing $128 million in bonds. JinkoSolar management announced that it would issue 800 million Yuan ($128 million) in bonds to fund its capital expenditure and working capital. The bonds mature in 6 years and offer an attractive annual yield of 8.99%. Furthermore, at the end of the third year the company can increase the interest rate by as much as 100 basis points. If there is a rate increase in the third year, bondholders have the option to ask the company to buy all or part of their bonds back. JinkoSolar is trading at the top of its 52-week range of $2.00-$10.20.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.